W
Wonngarm Kittanamongkolchai
Researcher at Mayo Clinic
Publications - 89
Citations - 1879
Wonngarm Kittanamongkolchai is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Odds ratio & Relative risk. The author has an hindex of 23, co-authored 79 publications receiving 1439 citations. Previous affiliations of Wonngarm Kittanamongkolchai include Columbia University & State University of New York Upstate Medical University.
Papers
More filters
Journal ArticleDOI
Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies
Wisit Cheungpasitporn,Charat Thongprayoon,Wonngarm Kittanamongkolchai,Narat Srivali,Peter J. Edmonds,Patompong Ungprasert,Oisin A. O'Corragain,Sira Korpaisarn,Stephen B. Erickson +8 more
TL;DR: The finding of this meta-analysis of observational studies suggests that PPI use is associated with hypomagnesemia and may impact clinical management of patients who are taking PPIs and at risk for hypomgnesemia related cardiovascular events.
Journal ArticleDOI
The Changing Incidence and Presentation of Urinary Stones Over 3 Decades
Wonngarm Kittanamongkolchai,Lisa E. Vaughan,Felicity Enders,Tsering Dhondup,Ramila A. Mehta,Amy E. Krambeck,Cynthia H. McCollough,Terri J. Vrtiska,John C. Lieske,Andrew D. Rule +9 more
TL;DR: The incidence of both symptomatic and asymptomatic kidney stones has increased dramatically, and the increased utilization of computed tomography during this period may have improved stone detection and contributed to the increased kidney stone incidence.
Journal ArticleDOI
AKI after Transcatheter or Surgical Aortic Valve Replacement
Charat Thongprayoon,Wisit Cheungpasitporn,Narat Srivali,Andrew M. Harrison,Tina M. Gunderson,Wonngarm Kittanamongkolchai,Kevin L. Greason,Kianoush Kashani +7 more
TL;DR: The postoperative incidence of AKI, defined by Kidney Disease Improving Global Outcomes guidelines, and major adverse kidney events in patients treated with TAVR with that in patientstreated with SAVR were compared to show no significant differences.
Journal ArticleDOI
Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis.
Wisit Cheungpasitporn,Charat Thongprayoon,Oisin A. O'Corragain,Peter J. Edmonds,Wonngarm Kittanamongkolchai,Stephen B. Erickson +5 more
TL;DR: A meta‐analysis evaluated the associations between consumption of sugar‐sweetened and artificially sweetened soda and CKD in patients who regularly drink soda and found no clear link between consumption and kidney disease.
Journal ArticleDOI
Pharmacokinetics of mycophenolic acid in severe lupus nephritis
Paungpaga Lertdumrongluk,Poorichaya Somparn,Wonngarm Kittanamongkolchai,Opas Traitanon,Somratai Vadcharavivad,Yingyos Avihingsanon +5 more
TL;DR: MPA pharmacokinetics were positively correlated with therapeutic responses of mycophenolate, suggesting that controlling the concentrations of MPA may improve its therapeutic efficacy in lupus nephritis.